Skip to main content
Equibles

Parkman Healthcare Partners LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 1777015 STAMFORD, CT
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,843,093
+$363,093 QoQ
Shares Held
475,279
-4.9% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#49
of 237 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parkman Healthcare Partners LLC holds $508,391,007 across 37 Biotechnology names. VIR ranks #29 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MBX
MBX Biosciences, Inc.
 800,173 $44,169,549
2 PTCT
Ptc Therapeutics, Inc.
 435,691 $35,539,314
3 RCUS
Arcus Biosciences, Inc.
 919,266 $28,340,970
4 GPCR
Structure Therapeutics Inc.
 485,661 $26,065,425
5 VRDN
Viridian Therapeutics, Inc.\DE
 1,377,576 $25,306,071
6 AGIO
Agios Pharmaceuticals, Inc.
 669,046 $24,828,297
7 INBX
Inhibrx Biosciences, Inc.
 256,950 $24,346,012
8 XENE
Xenon Pharmaceuticals Inc.
 397,379 $23,985,796

All Filings in VIR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,843,093 475,279
2026-03-31 $4,480,000 500,000